Page last updated: 2024-12-07

biotin hydrazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Biotin hydrazide is a biotin derivative that contains a hydrazine group. It is a versatile reagent for the labeling of biomolecules, such as proteins, nucleic acids, and carbohydrates. It is typically synthesized by reacting biotin with hydrazine. Biotin hydrazide can be conjugated to biomolecules through a variety of methods, including click chemistry and hydrazone formation. The hydrazine group of biotin hydrazide reacts with carbonyl groups on biomolecules, forming stable hydrazone linkages. Biotin hydrazide is a valuable tool for studying the localization and function of biomolecules in cells and tissues. It is commonly used for fluorescence microscopy, immunohistochemistry, and protein purification. The biotin label allows for detection and isolation of the labeled molecule through its strong affinity for streptavidin or avidin. The unique properties of biotin hydrazide have made it a valuable tool for researchers in a variety of fields, including biochemistry, molecular biology, and cell biology.'

biotin hydrazide: structure given in first source; RN given refers to (3aS-(3aalpha,4beta,6aalpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID83872
CHEMBL ID4458159
SCHEMBL ID33865
MeSH IDM0151011

Synonyms (37)

Synonym
biotin hydrazide
5-(2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanohydrazide
PROBES2_000011
(+)-biotin hydrazide, >=97% (tlc), powder
66640-86-6
5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanehydrazide
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, hydrazide, (3as,4s,6ar)-
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, hydrazide, (3as-(3aalpha,4beta,6aalpha))-
bd4vq48jnv ,
unii-bd4vq48jnv
AKOS016009615
(+)-biotin hydrazide
5-((3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanehydrazi de
BP-22107
SCHEMBL33865
biotin-hydrazide
5-((3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)pentanehydrazide
b2431 ,
mfcd00078532
(+)-biotin-hydrazide
J-516038
biotin hydrazone
5-[(3as,4s,6ar)-2-oxo-hexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanehydrazide
AS-74083
CHEMBL4458159
5-((3as,4s,6ar)-2-oxohexahydro-1h-thieno-[3,4-d]imidazol-4-yl)pentanehydrazide
HY-100215
CS-6036
biotin-nhnh2
(+)-biotin hydrazide;biotin hydrazide
KOZWHQPRAOJMBN-ZKWXMUAHSA-N
DTXSID50985217
1h-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-,hydrazide, (3as,4s,6ar)-
EX-A4437
A867417
LCZC2370
1h-thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, hydrazide, (3as-(3a.alpha.,4.beta.,6a.alpha.))-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1624247Cytotoxicity against human NIH-H460 cells assessed as cell viability at 50 nM after 48 hrs by MTT assay relative to control2019Bioorganic & medicinal chemistry letters, 03-01, Volume: 29, Issue:5
Design and synthesis of biotinylated cardiac glycosides for probing Nur77 protein inducting pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.55)18.7374
1990's15 (34.09)18.2507
2000's13 (29.55)29.6817
2010's13 (29.55)24.3611
2020's1 (2.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.71 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index35.06 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (24.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]